Suchergebnisse - "Borderi, Marco"

PubPharm (137)

1

Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process

enthalten in: The new microbiologica | 2024

von Maggiolo, F. | Lo Caputo, S. | Bonora, S. | +9

2

Pillars of long-term antiretroviral therapy success

enthalten in: Pharmacological research | 2023

von Taramasso, L. | Andreoni, M. | Antinori, A. | +36

3

Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centred approach. Consensus Guidance Using a Delphi Process

enthalten in: bioRxiv.org | 2022

von Maggiolo, F. | Caputo, S. | Bonora, S. | +9

4

Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir

enthalten in: AIDS (London, England) | 2022

von Calza, L. | Borderi, M. | Colangeli, V. | +5

5

Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV

enthalten in: Journal of cachexia, sarcopenia and muscle | 2021

von Bonato, M. | Galli, L. | Bossolasco, S. | +10

6

COVID-19 in patients with HIV-1 infection : a single-centre experience in northern Italy

enthalten in: Infection | 2021

von Calza, L. | Bon, I. | Tadolini, M. | +9

7

Enhancing care for people living with HIV : current and future monitoring approaches

enthalten in: Expert review of anti-infective therapy | 2021

von Maggiolo, F. | Bandera, A. | Bonora, S. | +15

8

Short Communication : No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir

enthalten in: AIDS research and human retroviruses | 2021

von Calza, L. | Borderi, M. | Colangeli, V. | +5

CommentIn: AIDS Res Hum Retroviruses. 2021 May;37(5):333-334. - PMID 33587009

9

Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

enthalten in: Infectious diseases (London, England) | 2021

von Calza, L. | Colangeli, V. | Borderi, M. | +5

10

Short Communication : No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine

enthalten in: AIDS research and human retroviruses | 2021

von Calza, L. | Borderi, M. | Colangeli, V. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]